개 정형외과 시장 : 시장 예측(2026-2032년)

The Canine Orthopedics Market is projected to grow by USD 473.60 million at a CAGR of 9.12% by 2032.

Canine orthopedics is advancing from episodic fracture repair toward comprehensive, evidence-led musculoskeletal care spanning trauma, developmental disorders, degenerative joint disease, sports medicine, rehabilitation, and lifelong mobility management. Demand is shaped by rising companion animal ownership, longer canine lifespans, increasing recognition of chronic osteoarthritis, and broader access to specialty veterinary hospitals. Clinicians are adopting improved diagnostic imaging, locking plate systems, joint stabilization techniques, arthroscopy, regenerative adjuncts, and structured rehabilitation protocols to support better functional outcomes. Search interest and clinical focus continue to center on high-value topics such as canine orthopedic implants, cranial cruciate ligament repair, hip dysplasia treatment, fracture fixation, veterinary orthopedic surgery, canine osteoarthritis management, and post-surgical rehabilitation. The sector's strategic importance lies in its ability to combine surgical precision, biomaterials science, imaging, digital planning, and multidisciplinary care to improve mobility, reduce pain, and enhance quality of life for dogs across age groups and breeds.

Transformative Shifts in the Canine Orthopedics Landscape

The canine orthopedics landscape is being reshaped by the convergence of advanced implant design, minimally invasive surgery, digital imaging, and personalized treatment planning. Traditional approaches based primarily on open surgery and generalized implant selection are giving way to patient-specific evaluation using radiography, computed tomography, gait analysis, and, in specialty settings, three-dimensional surgical planning. The clinical shift is especially visible in cranial cruciate ligament disease, patellar luxation, elbow dysplasia, hip dysplasia, complex fractures, angular limb deformities, and osteoarthritis, where treatment decisions increasingly integrate breed anatomy, body condition, activity level, age, and owner adherence capacity. Another major transition is the growing role of rehabilitation and multimodal pain management after orthopedic procedures. Veterinary teams are prioritizing physiotherapy, controlled exercise, weight management, nonsteroidal anti-inflammatory drugs, joint-support strategies, and follow-up imaging to improve recovery and reduce complications. At the same time, rising antimicrobial stewardship expectations, implant traceability, sterilization standards, and regulatory oversight are pushing providers and manufacturers toward stronger quality systems. These transformative shifts are making canine orthopedic care more precise, outcomes-oriented, and integrated across surgery, diagnostics, pain control, and rehabilitation.

Cumulative Impact of Artificial Intelligence on Canine Orthopedics

Artificial intelligence is beginning to influence canine orthopedics through imaging interpretation, surgical planning support, workflow optimization, and longitudinal outcome tracking. In diagnostic radiology, AI-assisted tools can support detection and measurement workflows for orthopedic abnormalities, although veterinary specialists remain essential for clinical interpretation and treatment decisions. Machine learning models are also being explored for gait assessment, lameness scoring, postoperative monitoring, and risk stratification, using inputs such as imaging findings, wearable activity data, breed characteristics, weight, age, and prior medical history. The cumulative impact of AI is likely to be strongest where it improves consistency, reduces administrative workload, and enables earlier intervention for mobility disorders. For orthopedic surgeons, AI-enabled planning can support implant sizing, angle measurement, deformity correction, and case documentation, particularly when paired with computed tomography and three-dimensional visualization. For general practices, decision-support tools may help identify cases requiring referral, improving continuity between primary and specialty veterinary care. However, responsible adoption requires validated datasets, transparent algorithms, data privacy safeguards, clinical governance, and avoidance of overreliance on automated outputs. In canine orthopedics, AI is best positioned as an augmenting technology that strengthens diagnostic confidence, efficiency, and follow-up quality while preserving veterinarian-led judgment.

Key Regional Insights Across Asia-Pacific, Europe, North America, Latin America, Africa, and Middle East

Asia-Pacific is gaining relevance in canine orthopedics as urban pet ownership, veterinary education, and specialty referral infrastructure expand across Japan, South Korea, Australia, China, India, and Southeast Asia. The region shows varied maturity, with advanced companion animal care and diagnostic capability in Japan, Australia, and South Korea, alongside rapidly developing urban veterinary services in China and India. Europe benefits from strong veterinary training standards, referral networks, animal welfare frameworks, and adoption of evidence-based approaches to orthopedic implants, rehabilitation, and pain management across major economies. North America remains one of the most clinically advanced regions for veterinary orthopedic surgery, supported by established specialty hospitals, high pet healthcare spending, broad availability of advanced imaging, and strong owner willingness to pursue procedures such as tibial plateau leveling osteotomy, fracture repair, arthroscopy, and total hip replacement. Latin America is developing through growing companion animal populations, expanding private veterinary clinics, and rising interest in orthopedic trauma care and canine osteoarthritis management, with Brazil and Mexico serving as important veterinary service hubs. Africa presents a mixed landscape, where canine orthopedic services are more available in urban private practices and academic veterinary centers, while broader access can be constrained by affordability, specialist availability, and diagnostic infrastructure. The Middle East is seeing greater uptake of premium companion animal services in urban centers, supported by modern clinics and rising demand for specialty care, though access remains concentrated in higher-income metropolitan areas. Across all regions, growth in clinical sophistication is closely tied to diagnostic imaging access, trained surgeons, implant quality, rehabilitation capacity, and owner awareness of musculoskeletal disease.

Key Group Insights Across NATO, G7, BRICS, European Union, ASEAN, and GCC

NATO member countries overlap substantially with developed veterinary markets in North America and Europe, where military, working-dog, police-dog, and service-dog health needs reinforce attention to orthopedic performance, injury repair, rehabilitation, and long-term mobility. G7 countries generally show strong adoption of advanced canine orthopedic diagnostics, surgical techniques, pain management, and rehabilitation, supported by mature veterinary sectors, established specialty referral systems, and higher owner capacity to pay for complex procedures. BRICS countries represent a diverse and strategically significant group, combining large companion animal populations, expanding veterinary education, and uneven but improving access to orthopedic surgery; China, India, and Brazil are particularly notable for increasing urban demand, while Russia and South Africa contribute established clinical expertise in key metropolitan centers. The European Union provides a structured environment for veterinary medical standards, professional mobility, animal welfare expectations, and medical device compliance, supporting consistent uptake of evidence-based orthopedic care across member states while still reflecting differences in reimbursement behavior and pet healthcare spending. ASEAN markets are increasingly important for canine orthopedics as urbanization, companion animal ownership, and private veterinary investment expand in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. Clinical capability varies widely, with advanced referral services concentrated in major cities and growing demand for fracture repair, cruciate ligament stabilization, and mobility care. The GCC is characterized by rising demand for premium veterinary services in affluent urban centers, where advanced diagnostics, imported implants, and specialist-led procedures are more accessible, particularly for companion dogs in high-income households. Across these groups, the most consistent differentiators are clinical training depth, implant availability, imaging infrastructure, regulatory clarity, and owner willingness to pursue advanced musculoskeletal care.

Key Country Insights in Canine Orthopedics

China is rapidly developing its companion animal healthcare infrastructure in major urban centers, with increasing demand for specialist canine orthopedic services as pet ownership, veterinary education, and private clinic investment rise. The United States leads in clinical adoption of advanced canine orthopedic procedures, with broad access to specialty referral hospitals, board-certified veterinary surgeons, computed tomography, rehabilitation services, and widely performed cranial cruciate ligament procedures. Japan has a highly developed companion animal care environment, strong diagnostic capability, and growing clinical attention to geriatric canine mobility as pets live longer. India is expanding from general veterinary care toward more sophisticated urban companion animal services, where orthopedic trauma, developmental disorders, cruciate ligament injury, and mobility care are increasingly recognized. Germany combines strong veterinary education, medical device discipline, and advanced specialty care, supporting sophisticated orthopedic treatment pathways. The United Kingdom has a mature veterinary referral system, strong professional standards, and established use of advanced imaging and orthopedic surgical techniques. Australia offers advanced veterinary specialty services, strong animal welfare awareness, and high uptake of referral-based orthopedic care in major cities. France demonstrates well-developed companion animal healthcare and consistent demand for orthopedic diagnostics, surgery, rehabilitation, and osteoarthritis management. South Korea is progressing quickly in advanced companion animal medicine, with modern clinics, increasing specialty training, and growing owner interest in surgical and rehabilitative orthopedic solutions. Italy and Spain both show robust companion animal cultures, established veterinary practice networks, and growing emphasis on pain management, rehabilitation, and orthopedic referral care. Canada shows evidence-based practice patterns similar to the United States, supported by high companion animal care standards and strong referral pathways in major provinces. Russia has specialized veterinary capability concentrated in major cities, with demand shaped by urban pet ownership and access to advanced equipment. Brazil is a leading Latin American country for companion animal medicine, with growing demand for fracture fixation, cruciate repair, and orthopedic rehabilitation across large metropolitan markets. Mexico is advancing through expanding private veterinary services and increased access to orthopedic trauma and joint care in urban centers.

Actionable Recommendations for Canine Orthopedics Industry Leaders

Industry leaders should prioritize clinically validated innovation that improves surgical accuracy, implant reliability, postoperative recovery, and long-term canine mobility. Manufacturers and service providers should invest in surgeon education, standardized instrumentation, implant traceability, and procedure-specific training for common conditions such as cranial cruciate ligament rupture, patellar luxation, hip dysplasia, elbow dysplasia, and complex fractures. Veterinary hospitals should strengthen referral pathways between general practitioners, orthopedic specialists, radiologists, anesthesiologists, and rehabilitation teams to improve continuity of care. Providers should also expand client education around early lameness detection, weight management, osteoarthritis control, and realistic recovery timelines, as owner adherence strongly affects outcomes. Digital tools should be adopted carefully, with emphasis on validated imaging workflows, secure medical records, teleconsultation for follow-up, and AI-assisted decision support that remains under veterinarian oversight. In emerging regions, partnerships focused on training, affordable implant access, and diagnostic capacity can improve care quality while widening access. Across all markets, leaders should align product development and clinical protocols with animal welfare standards, antimicrobial stewardship, biocompatibility evidence, and transparent postoperative outcome measurement.

Research Methodology

This executive summary is built using a structured secondary-research approach focused on verified veterinary, clinical, regulatory, and industry-relevant sources. The methodology emphasizes peer-reviewed veterinary orthopedic literature, professional veterinary association guidance, academic clinical resources, regulatory information related to veterinary medical devices and animal healthcare, and publicly available evidence on companion animal health trends. Insights are synthesized qualitatively to identify clinical adoption patterns, regional differences, technology shifts, and operational priorities in canine orthopedics. The analysis avoids market sizing, revenue estimation, market share calculation, or forecasting. Instead, it focuses on validated indicators such as veterinary infrastructure maturity, access to specialty surgery, diagnostic imaging availability, companion animal care standards, orthopedic disease prevalence in clinical literature, and adoption of evidence-based treatment pathways. Regional, group, and country insights are interpreted through the lens of healthcare access, veterinary training, urban companion animal ownership, regulatory environment, and availability of advanced orthopedic procedures. The approach is designed to support strategic decision-making while maintaining accuracy, transparency, and relevance for stakeholders in veterinary orthopedic surgery, implant development, rehabilitation, and companion animal healthcare.

Conclusion

Canine orthopedics is entering a more precise, integrated, and technology-enabled phase, driven by advanced surgical techniques, improved implants, diagnostic imaging, rehabilitation, and growing awareness of canine mobility disorders. The field is expanding beyond corrective surgery into continuous musculoskeletal health management, with emphasis on early diagnosis, pain control, functional recovery, and quality of life. North America, Europe, Japan, Australia, and South Korea demonstrate mature adoption of advanced orthopedic care, while China, India, Brazil, Mexico, ASEAN countries, and selected Middle Eastern markets are strengthening capabilities through urban veterinary investment and rising owner demand. Artificial intelligence, digital planning, and data-driven monitoring are set to improve efficiency and consistency, provided they are validated and integrated responsibly into veterinarian-led care. For industry participants, the strongest priorities lie in evidence-backed innovation, specialist training, rehabilitation integration, responsible digital adoption, and wider access to high-quality orthopedic solutions. Success will depend on aligning clinical performance, animal welfare, regulatory compliance, and owner education to deliver measurable improvements in canine mobility and long-term well-being.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Canine Orthopedics Market, by Product Type

• 7.1. Introduction
• 7.2. Disposables & Consumables
• 7.3. Implants
  • 7.3.1. External Fixators
  • 7.3.2. Intramedullary Nails
  • 7.3.3. Pins & Wires
  • 7.3.4. Plates
  • 7.3.5. Screws
• 7.4. Instruments
  • 7.4.1. Bone Cutters & Saws
  • 7.4.2. Bone Holding Forceps
  • 7.4.3. Drills & Reamers
• 7.5. Orthobiologics
  • 7.5.1. Bone Grafts
  • 7.5.2. Platelet-Rich Plasma (PRP)
  • 7.5.3. Stem Cell Therapy
• 7.6. Prosthetics & Orthotics
  • 7.6.1. Joint Braces
  • 7.6.2. Limb Prostheses
  • 7.6.3. Mobility Aids

8. Canine Orthopedics Market, by Mode Of Treatment

• 8.1. Introduction
• 8.2. Non-Surgical
• 8.3. Surgical

9. Canine Orthopedics Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Offline Sales
• 9.3. Online Sales
  • 9.3.1. E-Commerce Platforms
  • 9.3.2. Manufacturers Websites

10. Canine Orthopedics Market, by Application

• 10.1. Introduction
• 10.2. Amputation & Prosthetic Fitting
• 10.3. Fracture Repair
• 10.4. Joint Disorders
  • 10.4.1. Elbow Dysplasia
  • 10.4.2. Hip Dysplasia
  • 10.4.3. Luxating Patella
  • 10.4.4. Osteoarthritis
• 10.5. Joint Replacement
  • 10.5.1. Hip Replacement
  • 10.5.2. Knee Replacement
• 10.6. Ligament & Tendon Injuries
• 10.7. Limb Deformities
• 10.8. Post Operative Rehabilitation
• 10.9. Spinal Disorders

11. Canine Orthopedics Market, by End User

• 11.1. Introduction
• 11.2. Academic And Research Institutes
• 11.3. Ambulatory Surgical Centers
• 11.4. Veterinary Clinics
• 11.5. Veterinary Hospitals

12. Canine Orthopedics Market, by Region

• 12.1. Asia-Pacific
• 12.2. Europe
• 12.3. North America
• 12.4. Latin America
• 12.5. Africa
• 12.6. Middle East

13. Canine Orthopedics Market, by Group

• 13.1. NATO
• 13.2. G7
• 13.3. BRICS
• 13.4. European Union
• 13.5. ASEAN
• 13.6. GCC

14. Canine Orthopedics Market, by Country

• 14.1. China
• 14.2. United States
• 14.3. Japan
• 14.4. India
• 14.5. Germany
• 14.6. United Kingdom
• 14.7. Australia
• 14.8. France
• 14.9. South Korea
• 14.10. Italy
• 14.11. Canada
• 14.12. Russia
• 14.13. Brazil
• 14.14. Mexico
• 14.15. Spain

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. FPNV Positioning Matrix, 2025
• 15.3. Market Concentration Analysis, 2025
  • 15.3.1. Concentration Ratio (CR)
  • 15.3.2. Herfindahl Hirschman Index (HHI)
• 15.4. Recent Developments & Impact Analysis, 2025
• 15.5. Product Portfolio Analysis, 2025
• 15.6. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Arthrex Inc
• 16.2. B. Braun SE
• 16.3. BioMedtrix LLC
• 16.4. Boehringer Ingelheim International GmbH
• 16.5. Cencora Inc
• 16.6. DePuy Orthopaedics Inc
• 16.7. Elanco Animal Health Inc
• 16.8. Everost Inc
• 16.9. Fusion Implants Limited
• 16.10. GerVetUSA Inc
• 16.11. GPC Medical Limited
• 16.12. IMEX Veterinary Inc
• 16.13. Integra LifeSciences Corporation
• 16.14. Intrauma SpA
• 16.15. Jorgensen Laboratories
• 16.16. Narang Medical Limited
• 16.17. Orthomed UK Ltd
• 16.18. OrthoPets
• 16.19. Securos Europe GmbH
• 16.20. Siora Surgicals Private Limited
• 16.21. Stryker Corporation
• 16.22. Surgical Holdings
• 16.23. VetBionics
• 16.24. Veterinary Instrumentation
• 16.25. Vetoquinol S.A.
• 16.26. Vimian Group AB
• 16.27. Zoetis Inc